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  The  objective  of  this  study  was  to  explore  the 
immunomodulatory effects of betulinic acid (BA) extracted 
from the bark of white birch on mice. Female mice were 
orally administered BA for 14 days in doses of 0, 0.25, 0.5, 
and 1 mg/kg body weight. We found that BA significantly 
enhanced the thymus and spleen indices, and stimulated 
lymphocyte proliferation induced by Concanavalin A and 
lipopolysaccharide  as  shown  by  MTT  assay.  Flow 
cytometry revealed that BA increased the percentage of 
CD4
+ cells in thymus as well as the percentage of CD19
+ 
and the ratios of CD4
+/CD8
+ in spleen. BA increased the 
number of plaque-forming cell and macrophage phagocytic 
activity as indicated by a neutral red dye uptake assay, 
and the peritoneal macrophages levels of TNF-α were also 
increased. In contrast, serum levels of IgG and IgM and 
serum concentrations of IL-2 and IL-6 were significantly 
decreased in BA-treated mice compared to the control as 
assayed by haemagglutination tests and ELISA, respectively. 
T a k e n  t o g e t h e r ,  t h e s e  r e s u l t s  s u g g e s t  t h a t  B A  e n h a n c e s  
mouse cellular immunity, humoral immunity, and activity 
of  macrophages.  Thus,  BA  is  a  potential  immune 
stimulator and may strengthen the immune response of its 
host.
Keywords:  betulinic acid, cytokine, immunomodulation, 
macrophage, T cell subpopulation
Introduction 
Promoting human health by enhancing natural immune 
protection via bioactive compounds derived from plants 
has recently attracted considerable scientific interest and 
attention [19]. There are several advantages offered by 
bioactive compounds extracted from plants: low toxicity; 
high yield and easier obtainment; and favorable physiological 
functions,  e.g., they can improve immunomodulation and 
have anti-oxidative, anti-microbial, and anti-hypertensive 
functions [20]. Plant extracts have been widely used as 
biological additives and for drug development. Notably, 
preclinical development of bioactive natural products and 
their analogs as chemotherapeutic agents is required for 
their future clinic applications. 
Betulinic acid (BA) is a pentacyclic triterpene which is 
found in the stem bark of the plant white birch, and also in 
various other plants widespread in tropical regions such as 
Tryphyllum peltaum, Ancistrocladus heyneaus, Diospyoros 
leucomelas, Tetracera boliviana, and Syzygium formosanum 
[7,15,25]. BA and its derivatives have been the subject of 
intense study with focuses on their anti-cancer effects 
[22,23], anti-HIV [13], anti-bacterial, anti-inflammatory 
[24], antimalarial [6], anti-helminthic [10], and other 
pharmaceutical properties [2,12]. These effects may be due 
to their ability to modulate immune function rather than 
having a direct effect on infections and on cancer cells. In 
addition, various bioactive materials derived from plants 
exhibit an immunomodulatory ability [18]. Therefore, we 
propose that BA may be another valuable immunomodulator. 
The purpose of the present study was to determine whether 
BA affects mouse innate and adaptive immunity, which 
may lay fundamental groundwork for BA-based drug 
development.
Materials and Methods
Chemicals and antibodies
Concanavalin A (Con A), lipopolysaccharide (LPS), 
trypan blue, dimethylsulfoxide (DMSO), 3-(4,5- 
dimethylththiazoyl-2-yl)2,5-diphenyltetrazolium bromide 
(MTT), and Penicillin-Streptomycin were obtained from 
Sigma-Aldrich (USA). RPMI-1640 was obtained from 
Gibco (USA), and fetal bovine serum (FBS) was 
purchased from Hyclone (USA). Antibodies including rat 306    Jin-e Yi et al.
Fig. 1. Structure identification spectra of betulinic acid. (A) HPLC spectra of betulinic acid, (B) Mass spectrometry spectra of betulinic
acid, (C) 
1H-NMR spectra of betulinic acid, (D) 
13C-NMR spectra of betulinic acid.
anti-mouse CD4: fluorescein isothiocyanate (FITC) / 
CD8: R-phycoerythrin (RPE) (DC 034), rat anti-mouse 
CD19: FITC / CD3: RPE (DC 035) were obtained from BD 
(USA). The ELISA kits for assaying IL-2, IL-6, IL-10, and 
TNF-α were purchased from R&D System (USA).
Preparation of BA 
Plant  material:  The white birch bark samples were 
collected during spring, 2009 from Wroclaw, Poland. All 
the collected barks were immediately dried at 60
oC and 
stored in a dry and dark place.
Extraction, synthesis, and identification of BA: Fifteen 
g of dried bark were refluxed with 200 mL methanol for 3 
h at 70
oC. The methanol extract was dried under negative 
gauge pressure and dissolved in dichloromethane. After 
adding 2 M sodium hydroxide and mixing, the lower layer 
liquid was collected and then filtered under negative gauge 
pressure. The remaining substance was dissolved in ether, 
and water was added and mixed well. After that, the upper 
layer liquid was collected, filtered and fractionated with 
hexane and ethyl acetate (6：1). Betulin was obtained by 
silica gel column chromatography. The compound was 
subjected to Jones reagent oxidation to obtain betulonic 
acid. Reduction of betulonic acid by sodium borohydride 
in tetrahydrofuran provided a mixture of 3α- and 3β- 
hydroxyl products (5 : 95). Crystallization of the product 
mixture from methanol resulted in the 3β-hydroxyl 
product at a 75% yield.
Synthetic compound was a white powder and its molecular 
weight was 456 by mass spectrometry (MS) (Agilent 1100 
Series LC/MSD，USA). 
1H-NMR spectral (Varian 
INOVA-300, USA) data of the compound (CDCl3, 300 
MHz) is as following; δ: 0.754, 0.824, 0.934, 0.967, 0.977, 
1.691 (all s, each 3H, H-23, H-24, H-25, H-26, H-27, 
H-30), 2.252 (m, 1H, H-19), 3.20 (dd, 1H, H-3), 4.616 and 
4.744 (br s, each 1H, H-29). 
13C-NMR spectral data of the 
compound (CDCl3, 300 MHz) is as following; δ: 38.369 
(C-1), 27.377 (C-2), 78.991 (C-3), 38.842 (C-4), 55.312 
(C-5), 18.26 (C-6), 34.288 (C-7), 40.658 (C-8), 50.483 
(C-9), 37.187 (C-10), 20.824 (C-11), 25.469 (C-12), Immunomodulatory effects of betulinic acid from the bark of white birch on mice    307
38.682 (C-13), 42.412 (C-14), 29.68 (C-15), 32.129 
(C-16), 56.289 (C-17), 46.875 (C-18), 49.24 (C-19), 
150.386 (C-20), 30.527 (C-21), 37.011 (C-22), 27.972 
(C-23), 15.324 (C-24), 16.01 (C-25), 16.109 (C-26), 
14.675 (C-27), 180.526 (C-28), 109.688 (C-29), 19.351 
(C-30). The identity of BA was confirmed by comparing 
the results of MS, 
1H-NMR and 
13C-NMR analysis with an 
authentic sample (Fig. 1).
Animals and experiment designs
A total of 112 female Kunming mice weighing 18∼22 g 
(six weeks of age) were used in the present study. All 
animals were obtained from the Animal Service of Health 
Science Center in China. Mice were maintained on a 
laboratory standard diet and water ad libitum, and kept in 
an environment with constant temperature (23 ± 1
oC) and 
humidity (60 ± 10%) under a 12-h light/dark cycle. All 
animal care procedures were carried out pursuant to the 
guidelines of Laboratory Animal Care (NIH Publication 
No. 85-23, revised in 1985; USA). 
Animals were randomly classified to four groups: the 
control group, and 0.25, 0.5, and 1 mg/kg body weight 
BA-treated groups. Each experimental group consisted of 
seven mice. BA was administered to mice per os with 1% 
starch jelly for 2 weeks, and the control mice were given an 
equivalent amount of pure starch jelly; the total volume of 
the drug was 0.2 mL/20 g/mouse. Animal body weights 
were obtained weekly to determine the effects of BA on 
body weight and to adjust the administered amount of BA. 
After 2 weeks, the mice were anaesthetized with halothane 
and then sacrificed by cervical dislocation. Blood samples 
were collected through retro-orbital bleeding at specified 
time points under halothane anesthesia and assayed for cell 
counts, cytokines, and antibody titres.
Effects of BA on the immune apparatus index
The weights of spleen and thymus were measured after 
being excised from the animals. The thymus and spleen 
indices are expressed according to the following formula: 
weight of organ (mg)/body weight of mouse (mg) × 100.
Lymphocyte proliferation assay
Lymphocyte proliferation was determined by MTT assay. 
The spleens were removed using a sterile technique and 
placed in sterile plates containing Hank’s balanced salt 
solution (HBSS). The splenocytes were dissociated from 
the connective tissue capsule by gently pressing the organ 
through a 200 mesh sterile metal sieve. The sieve was 
rinsed with HBSS, and the suspension collected in sterile 
15 mL conical tubes. Red blood cells in the cell suspension 
were dissolved in haemolysed solution (7 g/L NH4Cl and 
2.6 g/L Tris-HCl). The resulting single cell suspension was 
washed twice with HBSS and centrifuged at 180 × g for 10 
min. The supernatant was discarded, and the cell pellets 
were re-suspended in 1 mL RPMI-1640 complete medium 
(supplemented with 10% (v/v) FBS, 100,000 units/L of 
penicillin and 0.1 mg/mL of streptomycin) at a density of 5 
× 10
6 cells/mL. The purity of isolated cells was 
approximately 95%, and the viability of splenocytes was 
always more than 95% as determined by a trypan blue dye 
exclusion assay. 
　　200 μL of lymphocytes were stimulated with 5 μg/mL 
Con A and/or 10 μg/mL LPS, and cultured in 96-well 
plates (Corning, USA) for 68 h at 37
oC in a humidified 
atmosphere of 5% CO2. Next, 15 μL of MTT (5 mg/mL) 
was added to each well. After a 4 h incubation at 37
oC and 
5% CO2, the medium was removed and 150 μL of DMSO 
were added to each well. The absorbance (A) was measured 
on Microwell Reader (Tecan Sunrise, Austria) at 490 nm. 
The experiments were performed in triplicate and the 
results were described as an average of A.
Determination of plaque forming cells (PFC) 
Sheep red blood cells (SRBC) were collected from a 
healthy sheep and stored in sterile Alsever’s solution 
(components: 2.05% glucose, 0.42% sodium chloride, 
0.8% tri-sodium citrate and 0.055% citric acid in distilled 
water) and then washed three times with 0.1 mol/L 
phosphate-buffered saline (PBS, pH 7.2) solution. Mice 
were immunized with 0.2 mL of 20% (v/v) SRBC solution 
(4 × 10
8 cells/mouse) by intraperitoneal, and the number of 
PFC was determined on days 4 after SRBC injection. 100 
μL of a splenocyte suspension (1 × 10
6 cells/mL) and 100 
μL of 10% (v/v) SRBC were mixed with 0.5 mL of 0.5% 
agarose and then transferred to a slide covered with a 0.5% 
agarose layer. After incubation at 37
oC in 5% CO2 and 
adequate reaction with guinea pig complement, the 
number of plaques was counted and expressed as those per 
1 × 10
6 viable splenocytes. 
Determination  of anti-SRBC  antibodies  in  mouse 
serum
Anti-SRBC haemagglutinin titre was determined on day 
4 after SRBC immunization. Blood was taken from the 
retro-ocular arteria of halothane anaesthetized mice. The 
sera were obtained by blood centrifugation at 3,000 rpm for 
10min and inactived at 56
oC for 30 min. The total and 
2-mercaptoethanol-resistant serum agglutination titres 
were defined by an active haemagglutination test according 
to the procedure previously described by Adler [1]. The 
titre of 2-mercaptoethanol-resistant antibody was roughly 
equivalent to that due to IgG in the serum, and thus the 
greater titre obtained without 2-mercaptoethanol was due 
to IgM. We found that serum from non-immunized mice 
didn’t contain anti-SRBC antibodies. 
Assay of thymocyte and splenocyte subpopulations
The mice were anaesthetized with halothane. The thymus 308    Jin-e Yi et al.
Fig. 2. Effect of betulinic acid on the weight index of the thymus
and spleen. Values are presented as the mean ± SD. *p ＜ 0.05 in 
betulinic acid-treated mice compared to the control. 
and spleen were removed and placed in disposable Petri 
dishes containing sterile, ice-cold PBS. The suspended 
cells were released from the lymphatic organs by passing 
them through a nylon mesh and centrifuging them onto a 
layer of Ficoll 400 (Pharmacia, Sweden) / Uropolinum 
75% (diatrizoate sodium and meglumine diatrizoate; 
Polpharma, Poland) at a 1：3 ratio and a density of 1.071. 
After centrifugation (3,500 rpm for 20 min) at 4
oC, the cells 
were collected from the interphase and washed twice with 
PBS supplemented with 1% bovine serum albumin (BSA) 
at 4
oC. After the second wash, the cells were suspended in 
PBS with 1% BSA at 1 × 10
7 cells/mL. The purity of 
isolated cells was approximately 95%, and the viability of 
each cell suspension was 90∼98% according to a trypan 
blue dye exclusion assay. The cells were re-suspended in 
100  μL of a PBS solution containing 1% BSA. The 
thymocytes and splenocytes were stained with rat 
anti-mouse CD4: FITC / CD8: RPE at the dilution 
recommended by the manufacturer (BD, USA). The 
splenocytes were also stained with rat anti-mouse CD19: 
FITC / CD3: RPE at the dilution recommended by the 
manufacturer (BD, USA). The cells were incubated at 4
oC 
for 30 min, and washed three times with ice-cold PBS 
buffer. The fluorescence was analyzed using a flow 
cytometer (FACS Calibur; Becton Dickinson, Germany). 
The distribution of the thymocyte and splenocyte markers 
was analyzed using software (CellQuest Pro; BD, USA). 
Peritoneal  macrophage  neutral  red  dye  uptake 
assay
Peritoneal macrophage culture: Peritoneal cells were 
harvested 3 d after intraperitoneal injection of 0.5 mL of a 
starch solution (5% concentration) and isolated using 10 
mL PBS with antibiotics (penicillin 10 U/mL and 
streptomycin 1 mg/mL). The cells were washed and plated 
in 100 μL RPMI-1640 medium supplemented with 10% 
FBS, penicillin (100 U/mL) and streptomycin (100 
μg/mL) at a density of 2 × 10
6 cells/mL in 96-well flat 
bottom plates. The cells were incubated for 3 h at 37
oC in 
an atmosphere of 5% CO2 and washed with PBS to remove 
non-adherent cells.
Neutral red uptake assay: After 24 h incubation at 37
oC 
in 5% CO2, the medium was removed, and 100 μL of 0.1% 
neutral red in PBS was added to each well and incubated 
for 3 h. The cells were washed with PBS three times, and 
100 μL of a 1% acetic acid solution (v/v) in 50% ethanol 
(v/v) was added to each well to extract the dye phagocytised 
by macrophages. After rapid agitation on a microtitre plate 
shaker, the absorbance was read at 540 nm. Tests were 
performed in triplicates from three experiments.
Cytokine levels by ELISA assays
Measurement of IL-2, IL-6, IL-10 concentrations in 
mouse serum: Blood was collected and centrifuged at 4
oC 
at day 14 from mice without or with BA treatment; the 
serum was stored at −80
oC before assay. The IL-2, IL-6, 
IL-10 contents in serum were determined by ELISA 
according to the manufacturer’s protocol. 
Measurement of TNF-α concentration in macrophage 
culture supernatants: After purifying the macrophages, 
incubation was continued for 18 h and the medium was 
replaced with fresh medium without FBS, but containing 
LPS from Escherichia coli at a concentration of 2.5 μg/ 
mL. Each culture was tested in triplicate. After 24 h of 
incubation, supernatants were removed and stored at −80
oC. 
A commercial ELISA kit was used to determine mouse 
TNF-α in macrophage culture supernatants according to 
the manufacturer’s instructions.
Statistical analysis
The one-way analysis of variance test and multiple 
comparison of Dunnett’s t-test were used to evaluate the 
difference of parametric samples between the control and 
BA-treated groups, and data were expressed as the mean ± 
SD of the values. A p value ＜0.05 was considered 
significant difference, and p ＜ 0.01 was considered to be 
an extremely significant difference between BA-treated 
mice and the control.
Results
Effects of BA on the immune apparatus index
Daily oral administration of BA did not result in any 
mortality. No obvious signs of toxicity were observed 
during the time of administration. Fig. 2 shows that the 
thymus indices of the mice in the high dose group (1 mg/kg 
body weight) and the spleen indices of the mice in the 
medium and high dose groups (0.5 mg/kg and 1 mg/kg 
body weight) were increased compared to those of the 
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Fig. 3. Effect of betulinic acid on lymphocyte proliferation. 
Splenocytes (5 × 10
6 viable cells/mL) were cultured with 
different concentrations of betulinic acid in either the presence or
absence of mitogens (LPS and/or Con A). Values are presented as 
the mean ± SD. *p  ＜ 0.05 in betulinic acid-treated mice 
compared to the control; **p ＜ 0.01 in betulinic acid-treated 
mice compared to the control. BA: betulinic acid, LPS: 
lipopolysaccharide, Con A: concanavalin A.
Fig. 4. Number of plaque forming cell in sheep red blood cells- 
immunized mice treated with betulinic acid. Values are presented
as the mean ± SD. *p ＜ 0.05, **p ＜ 0.01 vs. the control. PFC: 
plaque forming cells.
Fig. 5. The serum total resistant haemagglutination titre (IgM) 
and 2-mercaptoethanol-resistant haemagglutination titre (IgG) 
in sheep red blood cells-immunized mice treated with betulinic 
acid. Values are presented as the mean ± SD. *p ＜ 0.05, **p ＜
0.01 vs. the control.
Fig. 6. Effect of betulinic acid on peritoneal macrophage 
phagocytic activity. Values are presented as the mean ± SD. *p ＜
0.05, **p ＜ 0.01 vs. the control. 
Effect of BA on proliferative response of splenocytes 
to Con A and LPS
We compared the general effect of BA on splenocytes 
proliferation. Fig. 3 shows that BA caused a significant 
increase in proliferative response in Con A- and/or 
LPS-stimulated splenocytes; in particular, proliferation of 
splenocytes was dramatically increased in a dose- 
dependent manner after stimulation with Con A and LPS 
together. BA-treated splenocytes cultured in absence of 
mitogens did not show any significant proliferative effect. 
Effect of BA on the humoral response of SRBC- 
immunized mice
We next probed the effect of BA on the antibody response 
of humoral immunity in mice. From the plaque-forming 
cells assay, the number of PFC per 1 × 10
6 splenocytes was 
enhanced by 15.9%, 24.8%, and 54.3% in BA-treated 
groups (0.25 mg/kg, 0.5 mg/kg and 1 mg/kg, respectively), 
compared with those in the control (Fig. 4), and the 1 
mg/kg dose of BA had the most significant effect on PFC. 
Moreover, the production of total and 2-mercaptoethanol- 
resistant anti-SRBC serum haemagglutinins (IgM and 
IgG) was significantly decreased in BA-treated groups 
(Fig. 5). IgM was reduced by 21.8%, 17.4% and 14.5% and 
IgG was reduced by 24.9%, 18.8% and 15.5% in 310    Jin-e Yi et al.
Fig. 9. Effects of betulinic acid on IL-2, IL-6, and IL-10 in serum
and TNF-α in peritoneal macrophages. Values are presented as 
the mean ± SD. *p ＜ 0.05, **p ＜ 0.01 vs. the control. 
Fig. 8. Effects of betulinic acid on the percentage of thymocyte 
subpopulations. Values are presented as the mean ± SD. *p ＜
0.05, **p ＜ 0.01 vs. the control.
Fig. 7. Effects of betulinic acid on the percentage of splenocyte 
subpopulations. Values are presented as the mean ± SD. *p ＜
0.05, **p ＜ 0.01 vs. the control.
BA-treated groups (0.25 mg/kg, 0.5 mg/kg and 1 mg/kg, 
respectively). 
Effect of BA-treated on macrophage phagocytosis
To evaluate the activity of macrophage phagocytosis, we 
assessed the function of phagocytic capacity of peritoneal 
cavity phagocytes in mice. Fig. 6 shows that the 
macrophage phagocytic activity was significantly increased 
by BA at the medium and high doses (0.5 mg /kg and 1 
mg/kg) compared to the control group. No significant 
effects of BA on macrophage phagocytic activity were 
observed in mice at the dose of 0.25 mg/kg body weight.
Effect  of  BA  on  thymocyte  and  splenocyte 
subpopulations
Since BA enhanced the activities of lymphocytes 
possibly by altering the quantities of T and B cells or their 
subpopulations, we explored the effect of BA on 
thymocyte and splenocyte subpopulations. As shown in 
Fig. 7, the percentage of CD19
+ splenocytes and the 
splenic ratios of CD4
+/CD8
+ were significantly increased 
in BA-treated mice, whereas percentage of CD8
+ 
splenocytes was significantly decreased compared to the 
control group. There were no obvious changes in the 
percentage of total T cells (CD3
+) and CD4
+ T cells. As 
shown in Fig. 8, the percentage of CD4
+CD8
− thymocytes 
in BA-treated groups (0.25 mg/kg, 0.5 mg/kg and 1 mg/kg) 
was significantly increased by 8.81%, 11.37%, and 14.8%, 
respectively, while there were no significant changes in the 
percentage of CD8
+CD4
− and CD8
−CD4
− T cells, nor in 
the ratio of CD4
+/CD8
+ T cells. 
Effect of BA on cytokine levels 
Due to the fact that the normal serum level of TNF-α was 
below the detection limit, we measured the TNF-α level of 
peritoneal macrophages stimulated by LPS. As shown in 
Fig. 9, the peritoneal macrophages TNF-α level was 
significantly increased in all BA-treated groups compared 
to the control group. In contrast, the serum concentration of 
IL-2 and IL-6 decreased significantly at the 0.5 mg/kg 
dose. No significant changes in the IL-10 serum level were 
observed in mice with or without BA treatment. 
Discussion
In the current study, we clearly demonstrated that BA at 
various doses has a significant enhancement effect on 
cell-mediated immunity by promoting lymphocyte 
proliferation in response to immunological stimulation 
(via Con A or/and LPS) of T and B cells. Moreover, we 
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mice which indicates a positive effect of BA on humoral 
immune response.
Our observations were in accordance with other plant 
extracts; for example, extracts from Asparagus racemosus 
can activate murine splenocytes by markedly increasing 
their proliferation [14]. In the past few years, the 
percentage and ratio of two main lymphocyte T subsets, 
namely CD4
+ cells or T helpers, and CD8
+ or cytotoxic T 
cells, have been recognized as the most meaningful 
parameters for evaluating the balanced state of 
immunomodulation and response to homeostasis of the 
intrinsic immune system [9]. Previous studies have shown 
that some extractions from plants possess immune- 
stimulating capacity by increasing the percentage of CD4
+ 
cells or CD4
+/CD8
+ ratio [4,14]. The present study 
provided similar a result showing significant increase in 
the percentage of CD4
+ cells (Th cells) in thymus and the 
splenic ratios of CD4
+/CD8
+ in BA-treated groups. 
Furthermore, the percentage of CD19
+ cells (total B cell) 
was increased in the spleen of mice exposed to BA. As a 
result, an increase in the relative number of T and B cells 
could possibly result in stimulating the immune response 
in BA-treated mice.
Currently, it is thought that CD4
+ T cells differentiate into 
one of two effector phenotypes: T helper type 1 (Th1) cells 
which drive the immune response towards a cell-mediated 
immune response, and T helper type 2 (Th2) cells that 
promote a humoral or allergic response [8]. The functions 
of these subsets of T cells depend upon the specific types of 
cytokines that are generated, for example, IL-2, IFN-γ, and 
TNF-α by Th1 cells in contrast to IL-4, IL-5, IL-6, and 
IL-10 by Th2 cells. IL-10 is a negative immunoregulatory 
cytokine, which potentially suppresses Th1 functions such 
as the production of proinflammatory cytokines. These 
cytokines can dramatically affect not only the strength of 
the immune response, but also its character [21,29]. BA, an 
inhibitor of phospholipase A2, nitric oxide, and 
cyclooxygenase-2 [5,30] seems to be a modulator of 
cytokine production in Th1/Th2 cells. In our research, it 
was shown that BA significantly inhibited IL-2 (Th1) and 
slightly increased IL-10 (Th2) production. This observation 
suggests that BA has a mixed Th1 and Th2 adjuvant 
activity. However, its relative immunomodulatory effect 
turned out to be higher for Th2 as evidenced by a 
significant reduction in IL-2/IL-10 ratios, which is 
consistent with previous reports [30,31]. This data 
indicates that the compound stimulatory signals produced 
by immune cells decreased with the parallel increase in the 
inhibitory signals. On the hand, the serum level of IL-6 was 
decreased by BA. It is well-known that inappropriate 
regulation of IL-6 plays a protective as well as a deleterious 
role in antigen-specific immune-mediated diseases as 
characterized by low-grade inflammation [16,17]. IL-6 
can also exert multiple stimulatory effects on cell growth 
and inflammation [26], and it is involved in the initiation 
and maintenance of the acute phase inflammatory response 
in immunoregulation and non-immune events in cells and 
tissues outside the immune system [11]. 
TNF-α is produced by Th1 cells, some Th2 cells, and 
cytotoxic T cells in both soluble and membrane-associated 
forms, and it can also deliver activating signals to 
macrophages. Some members of the TNF receptor family 
can stimulate apoptosis. Th2 cells express B cell-activating 
effector molecules, whereas Th1 cells express effector 
molecules that activate macrophages. We observed that 
TNF-α production was increased by BA in a dose- 
dependant manner (from 0.25 to 1 mg/kg). Thus, it may be 
hypothesized that BA is a modulator of cytokine 
production by Th1/Th2 subpopulations, but Th2 preferential 
adjuvant activity and its influence on inflammatory 
reactions in organisms may be very complex. The extracts 
from the bark of white birch (a plant known to be rich in 
BA) are often used in phytopharmacology as anti-cancer, 
anti-HIV, anti-bacterial, anti-inflammatory and anti- 
helminthic agents [31]. However, further studies are 
required for conclusive correlations. 
Macrophages are not only the first line of defense in 
immune response to foreign invaders, but are also a kind of 
antigen-presentation cell which functions to present 
antigen-derived peptide fragments to T lymphocytes 
resulting in activating immunologically-competent T cells 
[3]. We found that BA also caused an increase in 
macrophage phagocytic activity. Some previous studies 
demonstrated that some agents of plant origin could 
enhance the capacity of the mononuclear phagocyte 
system resulting in stimulating host non-specific immunity 
[27,28]. Therefore, BA seems to enhance the antigen- 
presentation effect of macrophages by directly promoting 
phagocytosis capacity. Exposure to BA also caused an 
alteration in the serum levels of immunoglobulins. It is 
interesting to observe that BA was able to reduce the levels 
of IgM and IgG in mice. Since the concentration of 
immunoglobulins is associated with various pathological 
changes such as inflammation, activation of complement, 
and immune complex adhesion and immune deregulation, 
the decrease of IgM and IgG serum levels by BA can help 
attenuate these deleterious effects [4].
In conclusion, we have demonstrated that BA has the 
potential to enhance mouse immune function, including 
cellular immunity, humoral immunity, and activity of 
macrophages. Moreover, BA was a modulator of Th1/Th2 
cells cytokine production, which suggests that this agent 
can be used for modulation of the immune system and as 
anti-inflammatory agent in animals. Further studies should 
be undertaken to determine the clinical significance of 
these findings, particularly in those with impaired immune 
function and/or in those with cancer.312    Jin-e Yi et al.
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